Search Results

Showing results 131 - 140 for 1029

Evaluation of serum erythropoietin values as defined by 2016 World Health Organization criteria for the diagnosis of polycythemia vera. | Richard T. Silver MD Myeloproliferative Neoplasms Center

...NCP Journal Leuk Lymphoma Volume 58 Issue 11 Pagination 2768-2769 Date Published 2017 Nov ISSN 1029...

https://silvermpncenter.weill.cornell.edu/evaluation-serum-erythropoietin-values-defined-2016-world-health-organization-criteria-diagnosis

Use of eculizumab in autologous hematopoietic stem cell transplantation-associated thrombotic microangiopathy in two adults. | Pathology & Laboratory Medicine

...Laurence J Journal Leuk Lymphoma Volume 63 Issue 2 Pagination 473-477 Date Published 2022 Feb ISSN 1029...

https://pathology.weill.cornell.edu/research/publications/use-eculizumab-autologous-hematopoietic-stem-cell-transplantation-associated

PowerPoint Presentation

...Epigenomics. 2024;16(14):1013-1029. doi: 10.1080/17501911.2024.2375187. Epub 2024 Sep 3....

https://medicine.weill.cornell.edu/sites/default/files/id_division_newsletter_september_2024.pdf

Publications | Page 27 | Neurological Surgery

...Spine J. 18(6):1022-1029....

https://neurosurgery.weill.cornell.edu/research/publications?page=26&s=type&o=asc

Thalidomide, clarithromycin, lenalidomide and dexamethasone therapy in newly diagnosed, symptomatic multiple myeloma. | Myeloma Center

...Niesvizky R Journal Leuk Lymphoma Volume 55 Issue 12 Pagination 2842-9 Date Published 2014 Dec ISSN 1029...

https://www.myelomacenter.org/thalidomide-clarithromycin-lenalidomide-and-dexamethasone-therapy-newly-diagnosed-symptomatic

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. | Myeloma Center

...Chen-Kiang S Journal Leuk Lymphoma Volume 56 Issue 12 Pagination 3320-8 Date Published 2015 ISSN 1029...

https://www.myelomacenter.org/phase-12-study-cyclin-dependent-kinase-cdk46-inhibitor-palbociclib-pd-0332991-bortezomib-and

Phase 1/2 study of cyclin-dependent kinase (CDK)4/6 inhibitor palbociclib (PD-0332991) with bortezomib and dexamethasone in relapsed/refractory multiple myeloma. | Pathology & Laboratory Medicine

...Chen-Kiang S Journal Leuk Lymphoma Volume 56 Issue 12 Pagination 3320-8 Date Published 2015 ISSN 1029...

https://pathology.weill.cornell.edu/research/publications/phase-12-study-cyclin-dependent-kinase-cdk46-inhibitor-palbociclib-pd-0332991

'Real-world' Australian experience of pomalidomide for relapsed and refractory myeloma. | Neurological Surgery

...Mollee P Journal Leuk Lymphoma Volume 59 Issue 6 Pagination 1514-1516 Date Published 2018 06 ISSN 1029...

https://neurosurgery.weill.cornell.edu/research/publications/real-world-australian-experience-pomalidomide-relapsed-and-refractory-myeloma

Subcutaneous panniculitic-like T-cell lymphoma localized to a site of peginterferon alfa-2a administration. | Pathology & Laboratory Medicine

...Shreve CR, Geyer JT, Patel SS Journal Leuk Lymphoma Pagination 1-9 Date Published 2024 Feb 05 ISSN 1029...

https://pathology.weill.cornell.edu/research/publications/subcutaneous-panniculitic-t-cell-lymphoma-localized-site-peginterferon-alfa-2a

Cord blood chimerism and relapse after haplo-cord transplantation. | Myeloma Center

...Shore T Journal Leuk Lymphoma Volume 58 Issue 2 Pagination 288-297 Date Published 2017 02 ISSN 1029...

https://www.myelomacenter.org/cord-blood-chimerism-and-relapse-after-haplo-cord-transplantation

Showing results 131 - 140 for 1029